Before you begin treatment with FYARRO, it is important to know about the possible side effects and precautions so that you can be prepared to address them with your doctor if they occur. Contact your doctor immediately if you have any side effects.
Stomatitis (mouth ulcers and sores) are common during treatment with FYARRO and can be severe. Your doctor may also prescribe an alcohol-free mouthwash to help treat mouth sores
Thrombocytopenia (low blood platelets) and low blood cell counts including anemia (low red blood cell count) and neutropenia (low white blood cell count) may occur. Your doctor will perform periodic blood tests to check for potential side effects of FYARRO
Infections. FYARRO can make you more susceptible to infections. Tell your doctor right away if you develop a fever, chills, or do not feel well
Hypokalemia (low levels of potassium) and hyperglycemia (too much sugar in the blood) are possible during treatment with FYARRO
Inflammation of the lungs. Report any new or worsening respiratory symptoms to your doctor right away, such as trouble breathing
Hemorrhage (severe bleeding). If you experience bleeding, call your doctor right away
Allergic reaction (hypersensitivity). Contact your doctor or seek emergency care for any signs of an allergic reaction including rash, itching, hives, difficulty breathing or swallowing, flushing, chest pain, or dizziness
Pregnancy should be avoided during treatment with FYARRO due to the risk of fetal harm. Women and men should use contraception during treatment with FYARRO and for 12 weeks after the last dose. Tell your doctor if you suspect or know you've become pregnant. Women should not breastfeed while receiving FYARRO. Fertility issues including difficulty getting pregnant for both females and males may occur
Vaccines may not work as well if you are receiving FYARRO. The use of live vaccines or close contact with other people who have received a live vaccine should be avoided
Be sure to tell a doctor right away about any side effects you may be experiencing with FYARRO. In some cases, side effects may be serious—in the AMPECT study, 41% of patients experienced serious adverse reactions. Serious side effects are those that are life-threatening, require or extend a hospitalization, or result in disability, permanent damage, or a birth defect.
Stomatitis (mouth ulcers and sores)
Fatigue (tiredness)
Rash
Infection
Nausea
Edema (swelling)
Diarrhea
Musculoskeletal pain
Decreased weight
Decreased appetite
Cough
Vomiting
Dysgeusia (altered taste)
These are not all of the potential side effects of FYARRO. Talk to your doctor for more information and advice.
Some side effects may require your doctor to decrease the dose of FYARRO or skip one or more doses until the side effect goes away. You and your doctor may also choose to stop treatment with FYARRO if you are having side effects and/or are not seeing results with FYARRO
*FYARRO is not for everyone. Talk to your doctor to see if FYARRO may be right for you.
FYARRO® (sirolimus protein-bound particles for injectable suspension) (albumin-bound) is a prescription medicine used to treat adults with malignant perivascular epithelioid cell tumors (PEComa) that have spread to other parts of the body (metastatic) or cannot be removed by surgery (locally advanced, unresectable). It is not known if FYARRO is safe and effective in people with severe liver problems or in children.
Do not use FYARRO if you have had a severe allergic reaction to sirolimus or other medications that work similarly to sirolimus (eg, everolimus, temsirolimus), or human albumin.
FYARRO can cause the following serious side effects; depending on the severity, your doctor may decide to decrease your dose or stop treatment with FYARRO:
Before taking FYARRO, tell your doctor if you are breast feeding. It is not known if FYARRO could pass into breast milk and harm your baby. You should not breast feed during treatment with FYARRO and for 2 weeks after the last dose. Tell your doctor about all your medical conditions and the medicines you take, including prescription and nonprescription medicines, vitamins, and herbal supplements. Using FYARRO with certain other medicines can cause serious side effects. Tell your doctor before you start taking any new medicine. You should not drink grapefruit juice or eat grapefruit during your treatment with FYARRO. It may make the amount of FYARRO in your blood increase to a harmful level.
The most common side effects with FYARRO include the following: mouth ulcers or sores; feeling weak or tired; rash; infection; nausea; swelling of arms, hands, feet, ankles, face, or other parts of the body; diarrhea; body pain; decreased weight and appetite; cough; vomiting; and altered taste.
These are not all the possible side effects of FYARRO. Tell your doctor if you have any side effect that bothers you or does not go away. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Please see full Prescribing Information.
FYARRO® (sirolimus protein-bound particles for injectable suspension) (albumin-bound) is a prescription medicine used to treat adults with malignant perivascular epithelioid cell tumors (PEComa) that have spread to other parts of the body (metastatic) or cannot be removed by surgery (locally advanced, unresectable). It is not known if FYARRO is safe and effective in people with severe liver problems or in children.
Do not use FYARRO if you have had a severe allergic reaction to sirolimus or other medications that work similarly to sirolimus (eg, everolimus, temsirolimus), or human albumin.
FYARRO can cause the following serious side effects; depending on the severity, your doctor may decide to decrease your dose or stop treatment with FYARRO:
Before taking FYARRO, tell your doctor if you are breast feeding. It is not known if FYARRO could pass into breast milk and harm your baby. You should not breast feed during treatment with FYARRO and for 2 weeks after the last dose. Tell your doctor about all your medical conditions and the medicines you take, including prescription and nonprescription medicines, vitamins, and herbal supplements. Using FYARRO with certain other medicines can cause serious side effects. Tell your doctor before you start taking any new medicine. You should not drink grapefruit juice or eat grapefruit during your treatment with FYARRO. It may make the amount of FYARRO in your blood increase to a harmful level.
The most common side effects with FYARRO include the following: mouth ulcers or sores; feeling weak or tired; rash; infection; nausea; swelling of arms, hands, feet, ankles, face, or other parts of the body; diarrhea; body pain; decreased weight and appetite; cough; vomiting; and altered taste.
These are not all the possible side effects of FYARRO. Tell your doctor if you have any side effect that bothers you or does not go away. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
FYARRO® (sirolimus protein-bound particles for injectable suspension) (albumin-bound) is a prescription medicine used to treat adults with malignant perivascular epithelioid cell tumors (PEComa) that have spread to other parts of the body (metastatic) or cannot be removed by surgery (locally advanced, unresectable). It is not known if FYARRO is safe and effective in people with severe liver problems or in children.